Oncosenx

Developer of lipid nanoparticle and plasmid DNA for cancer therapy

placeSeattle, Washington, United States calendar_todayFounded 2018 groups13 employees language oncosenx.com

Registered entities

Innovation

1 patent family — focus: Human necessities, Chemistry & metallurgy; filing pace active. Cited 6 times.

YearFilings
20241
20251
20261

Investor mix

5 investors on record.

Investor typeCountShare
Venture capital480%
Bank & private debt120%
Coming soon